Anticancer researchHumansStomach NeoplasmsNeoadjuvant TherapyMaleFemale
Biological Features of Gastric Cancer After Neoadjuvant Chemotherapy.
Yuko Tamura, Masanori Oshi, Hiroki Kondo, Kohei Kasahara, Sho Sato, Takashi Kosaka, Hirotoshi Akiyama, Chikara Kunisaki, Itaru Endo
Published: 202610.21873/anticanres.17937
Abstract
BACKGROUND/AIM: Gastric cancer prognosis remains poor, and neoadjuvant chemotherapy (NAC) is not widely used in Japan. While docetaxel-based regimens have shown promise internationally, the biological basis of their efficacy is not fully understood.…
Preview only. Read the full abstract at the source